dr. mims on the emergence of targeted therapy in aml
Published 4 years ago • 60 plays • Length 0:52Download video MP4
Download video MP3
Similar videos
-
1:14
dr. mims on fda approval of ivosidenib in patients with aml
-
1:14
dr. mims on the beat aml master trial in aml
-
1:01
dr. mims on waiting for molecular tests before starting therapy in aml
-
1:16
dr. mims on developed mutations in aml
-
1:08
dr. lonial on the role of targeted therapy in aml and all
-
0:54
dr. mims on performing molecular profiling at diagnosis in aml
-
1:16
dr. mannis on targeted agents in the treatment of patients with aml
-
0:42
ros in cancer therapy: the bright side of the moon | rtcl.tv
-
5:17
impact of targeted therapies on treatment of mds and aml
-
2:07
what is meant by “targeted therapy” for aml?
-
1:18
dr. levis discusses the ideal use of quizartinib in flt3-itd aml
-
4:55
the challenges in aml-mrc
-
1:55
ai-driven targeted therapy in acute myeloid leukemia
-
19:40
targeted therapies in aml
-
1:33
dr. redner on the activity of venetoclax in aml
-
4:10
final thoughts on emerging therapies for aml
-
1:40
the role of menin inhibitors in the treatment of aml
-
1:36
innovations in mds and aml treatment
-
1:29
factors that prevent the personalization of therapies in aml